OBSERVATIONS IN DIAGNOSIS AND TREATMENT OF ORAL CANCER OVER THE PAST 45 YEARS Lessons remain in identifying malignant disorders and prevention across health settings
With
Professor Peter Thomson,
Head of Dentistry and Professor of Oral and Maxillofacial Sciences
James Cook University, Cairns
SEGMENT
Filmed in the Gold Coast | May 2026
Peter Thomson is Academic Head of Dentistry and Professor of Oral & Maxillofacial Sciences in the College of Medicine & Dentistry at James Cook University, Australia. A UK and Australian specialist in Oral & Maxillofacial Surgery and Oral Medicine, he qualified BDS from Manchester University and MBBS from Newcastle upon Tyne, gaining Fellowships in Dental Surgery from the Royal College of Surgeons of England, Ireland and Glasgow and a Fellowship in Surgery from Edinburgh, specializing in Head & Neck Oncology.
He completed MSc and PhD degrees in epithelial biology and cancer research at Manchester University, where he was Lecturer, before returning to Newcastle in 1996 as Professor of Oral & Maxillofacial Surgery. In 2009, he was appointed Hunterian Professor at the Royal College of Surgeons of England and in 2011 King James IV Professor at the Royal College of Surgeons in Edinburgh. In 2014, he gained a Manchester Higher Doctorate (DDSc) for oral oncology research, and in 2016 an MD from the University of Bath for his thesis on interventional management of potentially malignant disorders.
Developing an extensive international profile, Peter was appointed Visiting Professor at the National University of Singapore in 2014 before joining the University of Queensland’s School of Dentistry as Professor of Maxillofacial Surgery & Academic Clinical Director in 2016. He was recruited to The University of Hong Kong in October 2017 to become Associate Dean at the Faculty of Dentistry and Director of the Prince Philip Dental Hospital. He has also held Academic Head and Dean of Dentistry positions at the University of Central Lancashire, UK and Griffith University in Australia. He was invited to join James Cook University as Head of Dentistry in 2021.
Author of more than 350 research papers and 2 oral cancer textbooks, Peter is an internationally recognised authority in oncology, population health and dental education. His research emphasis encompasses oral carcinogenesis, epithelial cell biology, and the early diagnosis and interventional management of cancer.
Source: James Cook University website
Media access credit: Oral Health Association of Australia (OHAA)
-
MedTech Industry invited to NSW Parliament House
The inaugural NSW Parliament MedTech Showcase, hosted by The Hon Courtney Houssos MLC has highlighted the medical technology sector’s contribution to patient care, local manufacturing, jobs and the broader economy.
Speaking with the Australian Health Journal, Justin Foster, Associate Director of Advocacy and Government Relations at the Medical Technology Association of Australia (MTAA), said the event provided an important opportunity for industry and government to work together on shared priorities.
-
Enhancing occupational therapy service provision with military veterans
Almost half a million Australians have served with the Australian Defence Force. Given the high prevalence of physical and mental health conditions and complexity of civilian life adjustment after military service, high-quality occupational therapy services are critical. However, there is limited description of occupational therapy service provision to individuals funded by the Australian Department of Veterans’ Affairs to inform government policy.
A cross-sectional study, led by Professor Carol McKinstry, Professor of Occupational Therapy and Deputy Dean with La Trobe University’s Rural Health School at the Bendigo campus has used an online survey to collect information from occupational therapists providing services to Department of Veterans’ Affairs clients.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
